Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Ueckert

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approachHongtao Yu, Sebastian Ueckert, Lina Zhou, et al.
Clinical Pharmacokinetics|October 6, 2023
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic ImpairmentAnne-Kristina Mercier, Mikael Sunnåker, Sebastian Ueckert, et al.
Biometrics|August 17, 2023
How to analyze continuous and discrete repeated measures in small-sample cross-over trials?Johan Verbeeck, Martin Geroldinger, Konstantin Thiel, et al.
Blood Advances|January 9, 2026
RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059Anders Gabrielsen, Sebastian Ueckert, Catarina Nilsson, et al.
Lancet (London, England)|November 6, 2023
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trialHiddo J L Heerspink, Arihiro Kiyosue, David C Wheeler, et al.
JACC. Basic to Translational Science|June 25, 2025
Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic EffectsJunshi Liang, Sofia Nilsson, Johannes Wikström, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
CPT: Pharmacometrics & Systems Pharmacology|July 24, 2024
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approachHongtao Yu, Sebastian Ueckert, Lina Zhou, et al.
Clinical Pharmacokinetics|October 6, 2023
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic ImpairmentAnne-Kristina Mercier, Mikael Sunnåker, Sebastian Ueckert, et al.
Biometrics|August 17, 2023
How to analyze continuous and discrete repeated measures in small-sample cross-over trials?Johan Verbeeck, Martin Geroldinger, Konstantin Thiel, et al.
Blood Advances|January 9, 2026
RNA interference therapy targeting coagulation factor XI - a first-in-human trial of RBD4059Anders Gabrielsen, Sebastian Ueckert, Catarina Nilsson, et al.
Lancet (London, England)|November 6, 2023
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trialHiddo J L Heerspink, Arihiro Kiyosue, David C Wheeler, et al.
JACC. Basic to Translational Science|June 25, 2025
Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic EffectsJunshi Liang, Sofia Nilsson, Johannes Wikström, et al.
Pageof 3